DZ Bank’s Ascendis Pharma A/S ASND Stock Holding History

DZ Bank’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Sell	6,486 -17,511	-73%	-$4.09M	﹤0.01%	674
2026 Q1	$5.49M	Sell	23,997 -24,100	-50%	-$5.4M	﹤0.01%	487
2025 Q4	$10.3M	Sell	48,097 -5,633	-10%	-$1.16M	0.01%	372
2025 Q3	$10.7M	Buy	+53,730	New	+$10M	0.01%	373
2025 Q2	–	Sell	-2,524	Closed	-$393K	–	953
2025 Q1	$393K	Sell	2,524 -2,111	-46%	-$302K	﹤0.01%	790
2024 Q4	$638K	Hold	4,635	–	–	﹤0.01%	711
2024 Q3	$692K	Hold	4,635	–	–	﹤0.01%	714
2024 Q2	$632K	Buy	+4,635	New	+$631K	﹤0.01%	732
2018 Q2	–	Sell	-19,000	Closed	-$1.24M	–	865
2018 Q1	$1.24M	Buy	+19,000	New	+$1.07M	﹤0.01%	614

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

DZ Bank's ASND Position: Q2 2026 in Review

DZ Bank reduced its Ascendis Pharma A/S (ASND) stake by 73% in Q2 2026, selling an estimated $4.09M and leaving 6,486 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #674.

DZ Bank first reported a position in ASND in Q1 2018 and has held it in 9 quarters since. The position peaked at $10.7M in Q3 2025. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

DZ Bank held 6,486 shares of Ascendis Pharma A/S worth $1.73M as of Q2 2026.
DZ Bank sold 17,511 Ascendis Pharma A/S shares in Q2 2026, an estimated $4.09M.
Ascendis Pharma A/S made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #674 holding.
DZ Bank first reported a position in Ascendis Pharma A/S in Q1 2018 and has held it in 9 quarters since.
DZ Bank's Ascendis Pharma A/S position peaked at $10.7M in Q3 2025.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.